Your email address will be used for Wildy’s marketing materials only. We will never give your email address to any third party.
Special Discounts for Pupils, Newly Called & Students
Browse Secondhand Online
Wildy's will be closed on Monday 1st May and will re-open on Tuesday 2nd May.
Online book orders received during the time we are closed will be processed as soon as possible once we re-open on Tuesday.
As usual Credit Cards will not be charged until the order is processed and ready to despatch.
Any non-UK eBook orders placed after 5pm on the Friday 28th April will not be processed until Tuesday 2nd May. UK eBook orders will be processed as normal.
The successful achievement of pregnancies after pre-implantation genetic diagnosis (PGD) was reported in April 1990.
The technology is often used for patients who are at substantial risk of conceiving a pregnancy affected by a known genetic disorder, however from this technology other more controversial uses have arisen such as HLA typing to save the life of a sibling, sex selection for social reasons, the prevention of late onset diseases, or to prevent diseases which may be genetically predisposed to developing such as breast cancer.
The technology surrounding PGD is constantly developing, giving rise to new and unexpected consequences that create fresh ethical and legal dilemmas. Featuring internationally recognized experts in this field this book critically explores the regulation of PGD and the broader legal and ethical issues.
It looks at the regulatory situation in a number of jurisdictions including New Zealand, Asutralia and the UK, but it also explores a number of themes of wide significance including a historical consideration of PGD and its part in the creation of the "genetic embryo" as a political tool, the over-regulation of PGD, the place of the woman in the regulation of PGD and the ethical difficulties in handling this additional unexpected medical information yielded by new technologies.